After a July surge in buybacks and stake increases, nearly 100 Shanghai-listed companies on August 3 added new repurchases, shareholder increases, interim dividends and other confidence-building measures.
Shanghai-listed companies disclosed a record wave of market-support actions in July and followed with another concentrated batch of supportive announcements on August 3. By July 31, companies on the exchange had announced 89 new buyback plans with a combined upper limit of nearly 20.4 billion yuan and 67 new shareholder stake-increase plans with an upper limit of nearly 13.7 billion yuan, both exceeding the number of new additions in the entire second quarter. The push accelerated after A-share weakness in mid-July and included faster execution, with many companies moving quickly from disclosure to market purchases. On August 3, nearly 100 Shanghai-listed companies released additional measures spanning buybacks, stake increases, interim dividends, business updates tied to the 12th national centralized drug procurement and a no-sale pledge by a controlling shareholder. Bethel Automotive and Shandong Hi-Speed announced new buyback plans capped at a combined 400 million yuan, Soochow Securities said its controlling shareholder plans to increase its stake by no more than 200 million yuan, and 76 other companies reported progress on existing buyback and stake-increase programs. WuXi AppTec, Jiuzhou Pharmaceutical, Kingfa Science & Technology and Jiansheng Group also announced interim dividends, while several drugmakers said products had won bids in the state procurement program. Market participants and analysts said the dense disclosures signaled confidence in valuations and future growth and could help stabilize expectations in the Shanghai market.